Clinical Trials
85 trialsA Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults
Qilu Pharmaceutical Co., Ltd.
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
R-Pharm
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Panolos Bioscience
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults
Qilu Pharmaceutical Co., Ltd.
Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
68Ga-NOTA-PEG2-RM26 PET/CT, First in Man Study
Karolinska University Hospital
A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors
Tianjin Chasesun Pharmaceutical Co., LTD
AMT-151 in Patients With Selected Advanced Solid Tumours
Multitude Therapeutics Inc.
IMMUNOs-SBRT
Centre Georges Francois Leclerc
The Application of Novel Oncolytic Virus in Late Stage Solid Tumors
West China Hospital
CAT_PB
Lebanese University
A Study Of IMM47 In Subjects With Advanced Solid Tumors
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1 First-in-human Study of JS014
Anwita Biosciences
Neoantigen Derived DCs as Cancer Treatment
National Health Research Institutes, Taiwan
Safety and Toxicity Study of IMM27M in Patients With Advanced Solid Tumor
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
Immorna Biotherapeutics, Inc.
Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors
North China Petroleum Bureau General Hospital
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
Celularity Incorporated
Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors
Sorrento Therapeutics, Inc.
A Study of B1962, a PD-L1/VEGF Bispecific Antibody Fusion Protein, for Advanced Solid Tumors
Tasly Biopharmaceuticals Co., Ltd.
[18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy
CellSight Technologies, Inc.
NWTTPS
NWTraumatherapies
Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors
Binacea Pharma, Inc.
IMM40H Phase I Dose Escalation and Expansion
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
MICROBIOME
Imperial College London
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
Massachusetts General Hospital
A Study of Injection HB0025 in Patients With Advanced Solid Tumors
Huabo Biopharm Co., Ltd.
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK043 in Patients With Advanced Solid Tumor
Abbisko Therapeutics Co, Ltd
A Phase 1,Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors
Betta Pharmaceuticals Co., Ltd.
Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP
Guangzhou Institute of Respiratory Disease
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114
Akeso
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Monopteros Therapeutics Inc.
GAMING
ALTality, Inc.
Safety, Tolerability and Pharmacokinetics of the New Formulation SHR-1316 in Subjects With Advanced Tumors
Jiangsu HengRui Medicine Co., Ltd.
ATRiUM
Cambridge University Hospitals NHS Foundation Trust
A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer
Baptist Health, Louisville
RECAP
The Christie NHS Foundation Trust
A Study of PSB205 in Subjects With Advanced Solid Tumors
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
KYPHO-IORT
Loyola University
Sintilimab in the Treatment of Advanced and Refractory Pediatric Malignant Tumors
Sun Yat-sen University
A Study of HMPL-306 in Patients With IDH1 and/or IDH2 Mutation of Relapsed/Refractory Myeloid Leukemia/Neoplasms
Hutchmed
IORT
Loyola University
Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors
Henlix, Inc